Introduction 37
Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disease that 38 is the most prevalent form of dementia [1] . Symptoms initially present as episodic memory 39 loss and subsequently develop into widespread cognitive impairment. Two brain lesions are 40 pathological hallmarks of the disease: plaques and neurofibrillary tangles. Plaques are 41 extracellular aggregates of amyloid beta (Aβ) [2] , whereas, neurofibrillary tangles are 42 intraneuronal aggregates of hyperphosphorylated tau [3, 4] . In addition to these hallmarks, 43
the AD brain experiences many other changes, including metabolic and oxidative 44 dysregulation [5, 6] , DNA damage [7] , cell cycle re-entry [8], axon loss [9] and, eventually, 45 neuronal death [6, 10] . 46
Despite a substantial research effort, no cure for AD has been found. Effective treatments 47 are desperately needed to cope with the projected increase in the number of new cases as a 48 result of longer life expectancy and an ageing population. Sporadic onset is the most 49 common form of AD (SAD), for which age is the major risk factor. Familial AD (FAD)-a less 50 common (<1%), but more aggressive, form of the disease-has an early onset of pathology 51 using post-mortem human brain tissue, which may reflect the low sample numbers available 72 for such studies, differences in comorbidities between patients and confounding post-73 mortem procedures [17] . Although valuable, post-mortem studies also reflect the end-stage 74 of disease and, therefore, do not facilitate measurement of dynamic alterations in proteins as 75 AD progresses. 76
Animal models of AD, generated through transgenic over-expression of human APP or tau, 77 provide an opportunity to track proteomic alterations at pre-and post-pathological stages, 78 thus facilitating insight into the molecular mechanisms underlying disease development and 79 revealing new targets for drugs to prevent AD progression. Analyses of transgenic mice 80 models of AD have revealed some overlapping alterations in metabolic enzymes, kinases 81 and chaperones with human AD brain [17] . Only one study, however, has tracked alterations 82 in protein carbonylation over time, showing increases in oxidation of metabolic enzymes 83 (alpha-enolase, ATP synthase α-chain and pyruvate dehydrogenase E1) and regulatory 84 molecules (14-3-3 and Pin1) in correlation with disease progression [22] . 85
Adult-onset Drosophila models of AD have been generated by over-expressing human Aβ42 86 peptide exclusively in adult fly neurons using inducible expression systems. These models 87 have been shown to develop progressive neurodegenerative phenotypes, such as reduced 88 climbing ability, and shortened lifespan [23] . Taking advantage of the short lifespan of the fly, 89 and the flexible nature of the inducible model, we have performed a longitudinal study of the 90 brain proteome to capture the effects of Aβ42-toxicity in the brain from the point of induction 91 and across life. We identified 3093 proteins using label-free quantitative ion-mobility data 92 independent analysis mass spectrometry (IM-DIA-MS) [24] , 1854 of which were common to 93 healthy and Aβ42 flies. Of these, we identified 228 proteins that were significantly altered in 94 AD, some of which overlapped with normal ageing but the majority of which were ageing-95 independent. Proteins altered in response to Aβ42 were enriched for AD processes and 96 have statistically significant network properties in the brain protein interaction network. We 97 also show that these proteins are likely to be bottlenecks for signalling in the network, 98 suggesting that they comprise important proteins for normal brain function. Our data is a 99 valuable resource to begin to understand the dynamic properties of Aβ42 proteo-toxicity 100 during AD progression. Future functional studies will be required to determine the causal 101 role of these proteins in mediating progression of AD using model organisms and to 102 translate these findings to mammalian systems. 1A ), we confirmed a previously observed [23] reduction in lifespan following Aβ42 induction 107 prior to proteomic analyses ( Fig 1B) . 108
To understand how the brain proteome is affected as Aβ42 toxicity progresses, fly brains 109 were dissected from healthy and Aβ42 flies at 5, 19, 31 and 46 days, and at 54 and 80 days 110 for healthy controls, then analysed by label-free quantitative IM-DIA-MS ( Fig 1C,  111 Supplementary Data 1). 1854 proteins were identified in both healthy and Aβ42 fly brain 112 from a total of 3093 proteins ( Fig 1D) , which is typical for recent fly proteomics studies 113 [25, 26] . curves for healthy and Aβ42 flies. Aβ42 flies were induced to express Aβ42 at 2 days. 119
Markers indicate days that MS samples were collected. (C) Experimental design of the brain 120 proteome analysis. Aβ42 flies were induced to express Aβ42 at 2 days. For each of the 121 three biological repeats, 10 healthy and 10 Aβ42 flies were collected at 5, 19, 31 and 46 122 days, as well as 54 and 80 days for healthy flies. Proteins were extracted from dissected 123 brains and digested with trypsin. The resulting peptides were separated by nanoscale liquid For the 1854 proteins identified in both healthy and Aβ42 flies, we assessed the reliability of 130 our data. Proteins were highly correlated between technical and biological repeats ( Fig S1) . 131
We used principal component analysis of the protein abundances to identify sources of 132 variance ( Fig 1E) . Healthy and Aβ42 samples are clearly separated in the first principal 133 component, probably due to the effects of Aβ42. In the second principal component, 134 samples are separated by increasing age, due to age-dependent or disease progression 135 changes in the proteome. These results show that whilst ageing does contribute to changes 136 in the brain proteome (8.7% of the total variance), much larger changes are due to 137 expression of Aβ42 (70.6%) and this may reflect either a correlation with the ageing process 138 or progression of AD pathology. We confirmed this result using hierarchical biclustering of 139 protein abundances in Aβ42 versus healthy flies at 5 days ( Fig 1F) . The results reveal that 140 most proteins do not vary significantly in abundance with age in healthy flies, but many 141 proteins are differentially abundant in Aβ42 flies. 142
Analysis of brain proteome dysregulation in Aβ42 flies 143 We next identified the proteins that were significantly altered following Aβ42 expression in 144 the fly brain. To achieve this, we used five methods commonly used to analyse time course 145 RNA-Seq data [27] and classified proteins as significantly altered if at least two methods 146 detected them [28] . We identified 228 significantly altered proteins from 740 proteins that 147 were detected by one or more methods (Fig 2A) . A comparison of popular RNA-Seq 148 analysis tools [29] showed that edgeR [30] has a high false positive rate and variable 149 performance on different data sets, whereas, DESeq2 [31] and limma [32] have low false 150 positive rates and perform more consistently. We observed a similar trend in our data set. 151 limma and DESeq2 detected the lowest number of proteins, with 21 proteins in common ( were z score-transformed and clustered using a Gaussian mixture model. 163
Although these methods should be able to differentiate between proteins that are altered in 164
Aβ42 flies from those that change during normal ageing, we confirmed this by analysing 165 healthy flies separately. In total, 61 proteins were identified as significantly altered with age 166 ( Fig S3) , of which 30 were also identified as significantly altered in AD ( Fig 2B) and 31 in 167 normal ageing alone. These proteins are not significantly enriched for any pathways or 168 functions. Based on our results, we concluded that the vast majority of proteins that are 169 significantly altered in AD are not altered in normal ageing and that AD causes significant 170 dysregulation of the brain proteome. 171
To understand the dynamics of protein alterations following Aβ42 induction, we clustered the 172 profiles of proteins significantly altered in Aβ42 flies using a Gaussian mixture model (Fig  173   2C ). The proteins clustered best into four sets ( Fig S4) . In comparison to healthy flies, 174 cluster 1 contains proteins that have consistently higher abundance in Aβ42 flies. 175
Conversely, cluster 2 contains proteins that have lower abundance in Aβ42 flies. The 176 abundances of proteins from clusters 1 and 2 are affected from the onset of disease at day 177 5, and remain at similar levels as the disease progresses. Dysregulation of these proteins 178 may initiate AD pathogenesis, be involved in early stages of disease progression, or 179 represent defense mechanisms that could be harnessed for protection. Proteins in cluster 3 180 follow a similar trend in healthy and Aβ42 flies and increase in abundance with age. 181 However, cluster 4 proteins decrease in abundance as the disease progresses, whilst 182 remaining steady in healthy flies. Further work is required to determine whether reduction of 183 these proteins plays a causal role in disease pathogenesis that could be targeted 184 therapeutically, or whether their decline represents a protective response to damage. 185
We performed a statistical Gene Ontology enrichment analysis on each cluster, but found no 186 enrichment of terms. Furthermore, we also saw no enrichment when we analysed all 228 187 proteins together. 188 the test statistics, simulated by randomly sampling 183 nodes from the network 10,000 214 times. 215
We performed hypothesis tests and found that these proteins have statistically significant 216 network properties. Firstly, the significantly altered proteins make more interactions than 217 expected (mean degree p < 0.05; Fig 3B) . Therefore, these proteins may further imbalance 218 the proteome by disrupting the expression or activity of proteins they interact with. Secondly, 219 not only are these proteins close to each other (mean shortest path p < 0.05; Fig 3C) , but 220 also 129 of them form a connected component (size of largest connected component p < 221 0.01; Fig 3D) . These two pieces of evidence suggest that Aβ42 disrupts proteins at the 222 centre of the proteome. Lastly, these proteins lie along shortest paths between many pairs of 223 nodes (mean betweenness centrality p < 0.01; Fig 3E) and may control how signals are 224 transmitted in cells. Proteins with high betweenness centrality are also more likely to be 225 essential genes for viability [36] . Taken together, these findings suggest that the proteins 226 significantly altered in AD are important in the protein interaction network, and that 227 dysregulation of these proteins may have significant consequences for the brain proteome 228 and therefore function. 229
Predicting the severity of Aβ42-induced protein alterations 230 using network properties 231 We predicted how severely particular Aβ42-associated protein alterations may affect the 232 brain using two network properties-the tendency of a node to be a hub or a bottleneck. In 233 networks, nodes with high degree are hubs for communication, whereas nodes with high 234 betweenness centrality are bottlenecks that regulate how signals propagate through the 235 network. Protein expression tends to be highly correlated to that of its neighbours in the 236 protein interaction network. One exception to this rule, however, are bottleneck proteins, 237 whose expression tends to be poorly correlated with that of its neighbours [36] . This 238 suggests that the proteome is finely balanced and that the expression of bottleneck proteins 239 is tightly regulated to maintain homeostasis. We analysed the hub and bottleneck properties 240 of the significantly altered proteins and identified four hub-bottlenecks and five nonhub-241 bottlenecks that correlate with Aβ42 expression ( Fig 4A) and analysed how their 242 abundances change during normal ageing and as pathology progresses ( Fig 4B) . 243 to damage and is exacerbated by Aβ42 toxicity, or a protective mechanism against both 279 ageing and amyloid toxicity. 280
The cuticle protein Acp65Aa was also upregulated in Aβ42 flies, but levels fell sharply 281 between 5 and 19 days. However, it is surprising that we identified Acp65Aa in our samples, 282 as it is not expected to be expressed in the brain. One explanation may involve chitin, which 283 has been detected in AD brains and has been suggested to facilitate Aβ nucleation [41] . 284 Amyloid aggregation has previously been shown to plateau around 15 days post-induction 285
[42], which is around the same time that Acp65Aa drops in Aβ42 flies. Our results suggest 286 that Aβ42 causes an increase in Acp65Aa expression early in the disease, but further 287 experiments are needed to confirm this and to investigate its relationship with nucleation and 288 the aggregation process. 289 Hub-bottlenecks: Hsp70A, Gp93, Top2 and Act75B 290 291
The four hub-bottlenecks are consistent with Aβ42 inducing stress. Hsp70A, a heat shock 292 protein that responds to hypoxia, was significantly upregulated at early time-points (5 days) 293 in Aβ42 flies, compared to healthy controls which exhibited stable expression of this protein 294 throughout life. Although the levels dropped in Aβ42 flies between days 5 and 31 post-295 induction, at later time-points Hsp70A increased again, possibly suggesting a two-phase 296 response to hypoxia in Aβ42 flies. We found that Gp93-a stress response protein that 297 binds unfolded proteins-to be increased across age in Aβ42 flies compared to controls 298 possibly suggesting an early and sustained protective mechanism against Aβ42-induced 299 damage. DNA topoisomerase 2 (Top2), an essential enzyme for DNA double-strand break 300 repair, was decreased in Aβ42 flies, following a pattern which mirrors changes in its 301 expression with normal ageing. Double-strand breaks occur naturally in the brain as a 302 consequence of neuronal activity-an effect that is aggravated by Aβ polymerisation is ATP-dependent, so increased levels of G-actin may indicate reduced 318 intracellular ATP. In addition, ATP is important for correct protein folding and therefore 319 reduced levels may lead to increased protein aggregation in AD. 320
Due to the importance of these hub and bottleneck proteins in the protein interaction 321 network, we predict that AD-associated alterations in their abundance will likely have a 322 significant effect on the cellular dynamics of the brain. 323
Dysregulated genes are associated with known AD and ageing 324 network modules 325 Finally, we clustered the protein interaction network into modules and performed a Gene 326
Ontology enrichment analysis on modules that contained any of the 228 significantly altered 327 proteins. We saw no Gene Ontology term enrichment when we tested these proteins 328 clustered according to their abundance profiles ( Fig 2C) , presumably because the proteins 329 affected in AD are diverse and involved in many different biological processes. However, by 330 testing network modules for functional enrichment, we exploited the principle that interacting 331 proteins are functionally associated. Using a subgraph of the STRING network containing 332 the significantly altered proteins and their directly-interacting neighbours, we used MCODE 333
[47] to find modules of densely interconnected nodes. We chose to include neighbouring 334 proteins to compensate for proteins that may not have been detected in the MS experiments 335 due to the stochastic nature of observing peptides and the wide dynamic range of biological 336 samples [48] . The resulting subgraph contained 4842 proteins, including 183 of the 228 337 significantly altered proteins, as well as 477 proteins that were only identified in healthy or 338
Aβ42 flies and 3125 proteins that were not identified in our IM-DIA-MS experiments. 12 339 modules were present in the network (Fig 5A, Supplementary Data 2) . The proportion of 340 these modules that were composed of significantly altered proteins ranged from 0-8%. All 341 but one of the modules were enriched for processes implicated in AD and ageing ( Fig 5,  342 Supplementary Data 3), including respiration and oxidative phosphorylation, transcription 343 and translation, proteolysis, DNA replication and repair, and cell cycle regulation. These 344 modules contained two proteins that were recently found to be significantly altered in the 345 brain of AD mice [43] and are both upregulated four-fold in AD: adenylate kinase, an 346 adenine nucleotide phosphotransferase, and the armadillo protein Arm, involved in creating 347 long-term memories. 348 In humans, the greatest genetic risk factor for AD is the Ɛ4 allele of ApoE-an apolipoprotein 356 involved in cholesterol transport and repairing brain injuries [49] . A recent study showed that 357 ApoE is only upregulated in regions of the mouse brain that have increased levels of Aβ [43], 358 indicating a direct link between the two proteins. Although flies lack a homolog of ApoE, they 359 do possess a homolog of the related apolipoprotein ApoB (Apolpp) [50] , which contributes to 360 AD in mice [51,52] and is correlated with AD in humans [53, 54] . Interestingly, whilst it was 361 not identified by IM-DIA-MS, ApoB interacts with 12 significantly altered proteins in the 362 STRING network, so is included in the subgraph induced on the significantly altered proteins 363 and their neighbours. ApoB was found in the second highest scoring module that contains 364 proteins involved in translation and glucose transport ( Fig 5) [55]. 365
We analysed the 31 proteins significantly altered in normal ageing, but not AD. Of the 29 366 proteins that were contained in the STRING network, 24 interact directly with at least one of 367 the AD significantly altered proteins, suggesting an interplay between ageing and AD at the 368 pathway level. Using a subgraph of the STRING network induced on these proteins and their 369 1603 neighbours, we identified eight network modules that were enriched for ageing 370 processes [56], including respiration, unfolded protein and oxidative damage stress 371 responses, cell cycle regulation, DNA damage repair, and apoptosis. 372
Discussion 373
Despite the substantial research effort spent on finding drugs against AD, effective 374 treatments remain elusive. We need to better understand the molecular processes that 375 govern the onset and progression of the complex pathologies observed in AD. This 376 knowledge will help to identify new drug targets to treat and prevent AD. 377
Analysis of post-mortem human brain tissue is an important way to study dementia, but 378 cannot capture the progression of pathology from the initiation of disease. Due to their short 379 lifespan and ease of genetic manipulation, model organisms such as Drosophila 380 melanogaster provide a tractable system in which to examine the progression of AD 381 pathology across life. We performed a longitudinal study of the Drosophila brain proteome, 382 using an inducible model of AD, label-free quantitative IM-DIA-MS and network analyses. 383
We were able to track alterations in protein levels from the point of exposure to human Aβ42 384 and the widespread interaction of Aβ42 with brain signalling networks as pathology 385
progresses. 386
Our proteomic analyses identified Aβ42-induced alterations in levels of 228 proteins, which 387 clustered into four groups: those which were either elevated (cluster 1) or reduced (cluster 2) 388 in AD relative to controls throughout life, those which were altered in correlation with ageing 389 in healthy and Aβ42 flies (cluster 3), and those which changed in Aβ42 flies across life but 390 independently of ageing-dependent effects in healthy controls (cluster 4). Further 391 computational analysis of these proteins revealed significant network properties within the fly 392 brain proteome. Assessing hub and bottleneck properties, many of the Aβ42-induced 393 proteomic changes represented alterations in bottleneck proteins suggesting that they play 394 key roles in downstream cellular function. Of these, some display non-hub properties 395 indicating that they are important for maintaining cellular homeostasis in a targeted fashion, 396 whereas others also displayed hub properties suggesting that they are central in linking 397 cellular signalling pathways to maintain cell function. 398
We identified five nonhub-bottleneck proteins and four hub-bottleneck proteins, the 399 expression of which was altered in Aβ42 flies relative to controls across life. Due to the 400 importance of these hub and bottleneck proteins in the protein interaction network, we 401 predict that AD-associated alterations in their abundance will likely have a significant effect 402 on the cellular dynamics of the brain. Indeed, these proteins play key molecular roles in 403 metabolism (AscI, Echs1, Got2), protein homeostasis (Hsp70A, Gp93), and protection 404 against oxidative stress (mt:CoII) and DNA damage (Top2). These processes have been 405 shown to affect neuronal function and protection against proteo-toxicity. Alterations in these 406 proteins may represent either adaptive responses to the presence of abnormal protein 407 aggregates, such as Aβ42, or mediators of neuronal toxicity. Further functional genomic 408 studies are therefore required to establish the causal role of these processes in governing 409 onset and progression of AD pathology. 410
Assessing the human orthologs of these genes, identified ACTB (Act57B ortholog) has been implicated as a significant AD risk gene and central hub 426 node using integrated network analyses across GWAS [67] . 427 ACSL4, ECHS1, and HSP90B1 have no reported association with AD or related dementias, 428 however, which suggests that our study has potential to identify new targets in the molecular 429 pathogenesis of this disease. Our study also provides additional information about the 430 homeostasis of these proteins across life from the point of amyloid production. For example, 431 the abundances of Acs1 and Got2 are elevated following Aβ42 induction and continue to 432 increase with age relative to controls. Echs1 is reduced in Aβ42 flies compared to controls 433 but increases across life in parallel with ageing-dependent increases in this protein. Analysing Gene Ontology enrichment using network modules, to capture the diverse 441 biological processes modified in AD, we identified 12 modules enriched for processes 442 previously implicated in ageing and AD. This validates the use of our Drosophila model in 443 identifying progressive molecular changes in response to Aβ42 that are likely to correlate 444 with progression of cognitive decline in human disease. Further work is required to modify 445 the genes identified in our study at different ages, in order to elucidate whether they 446 represent mediators of toxicity as disease progresses, factors which increase neuronal 447 susceptibility to disease with age or compensatory protective mechanisms. Model organisms 448 will be essential in unravelling these complex interactions. Our study therefore forms a basis 449 for future analyses that may identify new targets for disease intervention that are specific to 450 age and/or pathological stage of AD. Proteins that were identified in both healthy and Aβ42 flies were considered for further 499 analysis. Missing data were replaced by the minimum abundance measured for any protein 500 in the same repeat [48] . The data were quantile normalised [73] , so that different conditions 501 and time points could be compared reliably. Quantile normalisation transforms the 502 abundances so that each repeat has the same distribution. 503
For PCA analysis, the data were log10-transformed and each protein was standardised to 504 zero mean and unit variance. Hierarchical biclustering was performed using the Euclidean 505 distance metric with the complete linkage method. Prior to clustering, proteins were 506 normalised to their abundance in healthy flies at 5 days. 507
Proteins that were identified by IM-DIA-MS in either healthy or Aβ42 flies were assessed for 508 overrepresentation of Gene Ontology terms using GOrilla [74] , which uses ranked lists of 509 target and background genes. Proteins were ranked in descending order by their mean 510 abundance. The type I error rate was controlled by correcting for multiple testing using the 511 Benjamini-Hochberg method at an FDR of 5%. 
